| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Jan 31, 2022 | Feb 2, 2022 | UroGen Pharma Ltd. | CEO | Sell | 42.5 | -8,195 | -1.33% | ✗ | $62.1K |
| Jan 3, 2022 | Jan 7, 2022 | UroGen Pharma Ltd. | CEO | Sell | 40.0 | -46,968 | -13.61% | ✗ | $429.8K |
| Jan 3, 2021 | May 21, 2021 | UroGen Pharma Ltd. | CEO | Sell | 42.5 | -3,425 | -1.41% | ✗ | $60K |
| Dec 14, 2020 | Dec 15, 2020 | UroGen Pharma Ltd. | CEO | Buy | 87.5 | +10,000 | 4.56% | ✗ | $185K |
| Nov 21, 2019 | Nov 22, 2019 | UroGen Pharma Ltd. | CEO | Buy | 95.0 | +7,530 | 83.50% | ✗ | $210.8K |
| Nov 20, 2019 | Nov 22, 2019 | UroGen Pharma Ltd. | CEO | Buy | 95.0 | +7,470 | 482.56% | ✗ | $209.2K |
| Nov 15, 2019 | Nov 18, 2019 | UroGen Pharma Ltd. | CEO | Buy | 91.3 | +1,548 | 100.00% | ✗ | $40.2K |